The University of Pennsylvania Health System (UPHS) and primary-care AI company K Health announced on May 27, 2026 a multi-year partnership to deploy a suite of integrated clinical agents directly inside Penn Medicine's electronic health record (EHR) systems and public-facing patient portals. The rollout, described by Penn Medicine as an enterprise-wide clinical AI architecture, is intended to replace the patchwork of standalone chatbots and intake forms that have proliferated across U.S. health systems.
Where the AI Will Show Up First
The collaboration will launch first inside Penn Medicine On-Demand, the system's virtual urgent care framework, before expanding into in-person primary care clinics and high-volume specialty divisions, including cardiology and dermatology. K Health's agents will sit between patients and clinicians, conducting a dynamic conversational intake and producing a pre-populated draft chart that flows directly into the EHR before the visit begins.
How the Intake Agents Work
K Health says its peer-reviewed intake interface, built on what the company describes as large lakes of real-world medical interactions and verified clinical datasets, replaces static digital forms with a guided dialogue that adapts to the patient's described reason for the visit. The system translates natural-language symptom descriptions, current medications and care history into structured medical data, then routes the resulting draft chart into the physician's existing EHR workflow for review.
"As health systems globally race to construct their consumer-facing digital strategies, Penn Medicine is treating clinical AI as foundational infrastructure," said Ran Shaul, K Health's co-founder and chief product officer, in a statement reported by HIT Consultant.
Why Penn Medicine Is Standardizing on One Vendor
Mitchell Schnall, MD, PhD, senior vice president for data and technology solutions at Penn Medicine, said the system sees AI as a clinical opportunity to optimize direct patient care, citing the need to evaluate how advanced AI models scale across routine institutional care. K Health, which has raised $384 million to date, said the two parties will co-develop peer-reviewed clinical research to build evidence on how autonomous intake agents affect workflow efficiency and patient compliance.
A Wider Wave of Clinical AI Integration
The Penn Medicine deal lands alongside a broader push to embed AI deeper into medical workflows. Subtle Medical just won FDA clearance for its AI PET imaging tool, and AiM and Siemens Healthineers are working on MRI-guided brain surgery robotics. On the operating-room side, Cornerstone Robotics secured a CE mark for its Sentire surgical platform, and Intuitive added telepresence and extended force feedback to the da Vinci 5.
What to Watch Next
Penn Medicine's deployment is being closely watched as a test of whether large U.S. academic health systems can move beyond pilot AI projects and into core infrastructure decisions. Initial outcomes will likely focus on whether the K Health intake layer reduces clinician charting time and shortens wait times in virtual urgent care before the system commits to broader rollout into specialty divisions.
Reporting based on coverage from HIT Consultant and statements from Penn Medicine and K Health.